RARA and acute promyelocytic leukemia: However, if managed promptly and appropriately, the majority of patients are cured with treatment regimens that include a combination of targeted biologic therapies including all-trans retinoic acid and arsenic trioxide.26 Due to the unique characteristics of APL with PML-RARA fusion gene, this entity is not specifically covered in the remainder of this review.